Rulemaking action by the Iowa Board of Pharmacy has been published in the Iowa Administrative Bulletin as follows: 

Adoption

  • ARC 8175C has been adopted and filed to amend Chapter 10, “Controlled Substances.”
    • The amendment temporarily places nine substances into Schedule I of the Iowa CSA in response to similar action taken by the federal DEA.
    • The amendment is effective September 11, 2024.
  • ARC 8176C has been adopted and filed to amend Chapter 10, “Controlled Substances.”
    • The amendment temporarily places one substance into Schedule I of the Iowa CSA in response to similar action taken by the federal DEA.
    • The amendment is effective September 11, 2024.

Regulatory Analysis

  • A regulatory analysis has been published on proposed new 481 Chapter 550, “Definitions,” and Chapter 551, “Licenses, Registrations, and Permits.”
    • The regulatory analysis proposes to establish two new chapters to provide definitions to be applicable in 481 Chapters 550 through 557 and the requirements for a license, registration or permit from the Board of Pharmacy. 
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 1:00 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 552, “Standards - Practice of Pharmacy.”
    • The regulatory analysis proposes to establish this chapter to provide standards and requirements for the practice of pharmacy in the state of Iowa.
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 1:30 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 553, “Controlled and Precursor Substances.”
    • The regulatory analysis proposes to establish this chapter to provide standards and requirements for controlled and precursor substances.
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 2:00 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 554, “Operational Standards - Distribution and Drug Supply Chain.”
    • The regulatory analysis proposes to establish this chapter to provide standards and requirements for entities within the drug supply chain. 
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 2:30 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 555, “Standards - Drugs in EMS Programs.”
    • The regulatory analysis proposes to establish this chapter to provide standards and requirements for the utilization of drugs in EMS programs.
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 2:45 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 556, “Iowa Prescription Monitoring Program.”
    • The regulatory analysis proposes to establish this chapter to provide information about the Iowa Prescription Monitoring Program.
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 3:00 p.m.
  • A regulatory analysis has been published on proposed new 481 Chapter 557, “Board Operations.”
    • The regulatory analysis proposes to establish this chapter to provide information about the Board of Pharmacy operations.
    • Public comments can be submitted no later than 4:30 p.m. on August 29, 2024.
    • A public hearing will be held August 29, 2024 at 3:30 p.m.